Annaida Technologies SA has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance ("µNMR") at a scale 10-fold better than existing technologies, enabling non invasive chemical analysis at the scale of a single human embryo. µNMR opens new global markets in assisted reproductive technology ("ART"), enabling non-invasive embryo viability screening for in vitro fertilization ("IVF"), as well as in biochemical research.
29.04.2025
Annaida obtains undisclosed pre-series A funding (startupticker.ch)
06.02.2025
ZKB Pionierpreis Technopark 2025: Die Nominierten (startupticker.ch)
06.05.2024
Innosuisse funded 45 Start-up innovation projects (startupticker.ch)
12.01.2024
Pushing at the boundaries of IT, in healthcare and beyond (startupticker.ch)
23.04.2021
Tech4Eva draws global interest (startupticker.ch)
01.02.2020
Additional team member
No Jobs
No videos and documents
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Website:
www.annaida.ch
Headquarter:
Lausanne
Foundation Date:
August 2018
Technology:
Sectors: